Literature DB >> 17609975

Verrucous carcinoma (Buschke-Lowenstein) arising in a sacrococcygeal pilonidal sinus tract: report of a case.

Oner Mentes1, Metin Akbulut, Mahir Bagci.   

Abstract

PURPOSE: Pilonidal sinus disease is usually located in the sacrococcygeal region. Verrucous carcinoma (Buschke-Lowenstein) is a rare variant of squamous cell carcinoma with distinct clinical and histopathologic features, with a favorable prognosis. Malignant degeneration is an infrequent complication, which is associated with a high recurrence rate and poor prognosis.
MATERIALS AND METHODS: A case report is presented.
RESULTS: We report a 48-year-old man with a 10-year history of recurrent pilonidal sinus disease presented with a sacrococcygeal verrucous carcinoma arising in the pilonidal sinus tract and associated with good prognosis. After operation, a 5-year disease-free follow-up was observed.
CONCLUSION: Careful inspection of the pilonidal area in all chronic and long-standing inflammatory processes is important and should be evaluated for malignant transformation.

Entities:  

Mesh:

Year:  2007        PMID: 17609975     DOI: 10.1007/s00423-007-0209-y

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  19 in total

Review 1.  Recurrent squamous-cell carcinoma arising in sacrococcygeal pilonidal sinus tract: report of a case and review of the literature.

Authors:  B Abboud; H Ingea
Journal:  Dis Colon Rectum       Date:  1999-04       Impact factor: 4.585

2.  Malignant degeneration: an unusual complication of pilonidal sinus disease.

Authors:  S Pekmezci; M Hiz; K Saribeyoglu; D Akbilen; M Kapan; C Nasirov; H Taşçi
Journal:  Eur J Surg       Date:  2001-06

3.  Pilonidal sinus carcinoma.

Authors:  J L TERRY; J C GAISFORD; D C HANNA
Journal:  Am J Surg       Date:  1961-09       Impact factor: 2.565

Review 4.  Cancer complicating chronic ulcerative and scarifying mucocutaneous disorders.

Authors:  R P Kaplan
Journal:  Adv Dermatol       Date:  1987

5.  Treatment of malignancy arising in pilonidal disease.

Authors:  E de Bree; F A Zoetmulder; M Christodoulakis; B M Aleman; D D Tsiftsis
Journal:  Ann Surg Oncol       Date:  2001 Jan-Feb       Impact factor: 5.344

6.  Verrucous carcinoma of the vulva containing human papillomavirus-11. Case report.

Authors:  M E Crowther; J H Shepherd; C Fisher
Journal:  Br J Obstet Gynaecol       Date:  1988-04

7.  Squamous cell carcinoma in a chronic pilonidal sinus.

Authors:  T A Jeddy; R H Vowles; J A Southam
Journal:  Br J Clin Pract       Date:  1994 May-Jun

8.  An unusual variant of squamous cell carcinoma (inverted verrucous carcinoma) arising in a pilonidal sinus.

Authors:  A M Anscombe; P Isaacson
Journal:  Histopathology       Date:  1983-01       Impact factor: 5.087

9.  Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

Authors:  H Bartelink; F Roelofsen; F Eschwege; P Rougier; J F Bosset; D G Gonzalez; D Peiffert; M van Glabbeke; M Pierart
Journal:  J Clin Oncol       Date:  1997-05       Impact factor: 44.544

Review 10.  Sacrococcygeal pilonidal sinus: historical review, pathological insight and surgical options.

Authors:  S Chintapatla; N Safarani; S Kumar; N Haboubi
Journal:  Tech Coloproctol       Date:  2003-04       Impact factor: 3.781

View more
  2 in total

1.  Buschke-Lowenstein tumor.

Authors:  Jose M Martin; Inmaculada Molina; Carlos Monteagudo; Nuria Marti; Veronica Lopez; Esperanza Jorda
Journal:  J Dermatol Case Rep       Date:  2008-12-27

2.  Squamous cell carcinoma arising from chronic sacrococcygeal pilonidal disease: a case report.

Authors:  Nick Michalopoulos; Konstantinos Sapalidis; Styliani Laskou; Evangelia Triantafyllou; Georgia Raptou; Isaak Kesisoglou
Journal:  World J Surg Oncol       Date:  2017-03-17       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.